Benefit Managers Profit by Specialty Drug Rights

April 18th, 2008 at 9:30 pm (Drugs (Pharmaceuticals), Express Scripts Incorporated|ESRX|NASDAQ, Health Insurance and Managed Care, Medicine and Health)

A growing portion of some drug benefit managers’ revenue comes from being exclusive or semi-exclusive distributors of expensive specialty drugs.

Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/04/19/business/19specialty.html?ex=1366344000&en=c734174973cb1055&ei=5088&partner=rssnyt&emc=rss,By MILT FREUDENHEIM

Comments

Employers Pressed by Increasing Costs of Specialty Drugs

April 18th, 2008 at 5:50 pm (Drugs (Pharmaceuticals), Express Scripts Incorporated|ESRX|NASDAQ, Health Insurance and Managed Care, Medicine and Health)

A growing portion of some drug benefit managers’ revenue comes from being exclusive or semi-exclusive distributors of expensive specialty drugs.

Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/04/19/business/19specialty.html?ex=1366257600&en=5dcd16f291c7d04e&ei=5088&partner=rssnyt&emc=rss,By MILT FREUDENHEIM

Comments

Paid to Control Drug Costs, Yet Pushing Some Prices Higher

April 18th, 2008 at 1:14 pm (Drugs (Pharmaceuticals), Express Scripts Incorporated|ESRX|NASDAQ, Health Insurance and Managed Care, Medicine and Health)

A growing portion of the revenue of some drug benefit managers comes from acting as exclusive or semi-exclusive distributors of expensive specialty drugs.

Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/04/19/business/19specialty.html?ex=1366257600&en=5dcd16f291c7d04e&ei=5088&partner=rssnyt&emc=rss,By MILT FREUDENHEIM

Comments